暗盤收盤 | 凱萊英、固生堂、北海康成-B輝立暗盤跌4.64%、漲18.97%、跌11.33%,富途暗盤跌4.12%、漲18.28%、跌8.54%
12月9日,凱萊英(06821)輝立暗盤下跌4.64%,報於370港元,成交額6390萬港元;富途暗盤下跌4.12%,報於372港元,成交額594.3萬港元。發行價爲388港元。
公司簡介:凱萊英醫藥集團(股票代碼:002821.SZ)是一家全球領先的CDMO公司,爲全球新藥提供高質量的研發、生產一站式服務。以加速新藥上市,延長生命的質量爲己任,依託持續技術創新,爲國內外製藥公司、生物技術公司提供藥品全生命週期一站式CMC服務,加快新藥開發及應用。
固生堂(02273)輝立暗盤上漲18.97%,報於34.5港元,成交額3700萬港元;富途暗盤上漲18.28%,報於34.3港元,成交額624.37萬港元。發行價爲29港元。
公司簡介:我們爲中國一家中醫醫療健康服務提供商,以基礎醫療爲重心,建立了線上醫療健康平臺與線下醫療機構相結合的中醫平臺,並將中醫與西醫結合,爲客戶提供貫穿疾病診療和醫療健康管理全過程的全面醫療健康解決方案。
北海康成-B(01228)輝立暗盤下跌11.33%,報於10.8港元,成交額2210萬港元;富途暗盤下跌8.54%,報於11.14港元,成交額123.91萬港元。發行價爲12.18港元。
公司簡介:CANbridge成立於2012年,是一家專注於中國罕見疾病領域的全球領先生物製藥公司,致力於轉化療法的研究、開發和商業化。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.